Cargando…

Diabetes or calcium channel blocker contribute to cerebral hemodynamics after bypass surgery in adult patients with moyamoya disease

BACKGROUND: Moyamoya disease (MMD) is a teratogenic and lethal disease. However, existing studies do not sufficiently indicate the impact factors. Therefore, we investigated the different impact factors on cerebral hemodynamics after revascularization in patients with MMD. METHODS: We retrospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Shoumeng, Cai, Linzhi, Tian, Qi, Wei, Heng, Wang, Guijun, Wang, Jianfeng, He, Peibang, Liao, Jianming, Zhang, Shenqi, Chen, Qianxue, Li, Mingchang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816730/ https://www.ncbi.nlm.nih.gov/pubmed/36620177 http://dx.doi.org/10.21037/qims-22-407

Ejemplares similares

The eIF4A Inhibitor Silvestrol Blocks the Growth of Human Glioblastoma Cells by Inhibiting AKT/mTOR and ERK1/2 Signaling Pathway
por: Zhang, Wei, et al.
Publicado: (2022)

A web-based dynamic nomogram for rupture risk of posterior communicating artery aneurysms utilizing clinical, morphological, and hemodynamic characteristics
por: Wei, Heng, et al.
Publicado: (2022)

Efficacy and safety of embolization for arteriovenous malformations of the basal ganglia and thalamus via the transarterial approach
por: Zhang, Wei, et al.
Publicado: (2022)

Different Hemodynamic Characteristics and Resulting in Different Risks of Rupture Between Wide-Neck and Narrow-Neck Aneurysms
por: Wei, Heng, et al.
Publicado: (2022)

Effect of Calcium Channel Blockers versus Diuretics for Hypertension
por: Chunxue, Yi, et al.
Publicado: (2022)

CXCR4-BTK axis mediate pyroptosis and lipid peroxidation in early brain injury after subarachnoid hemorrhage via NLRP3 inflammasome and NF-κB pathway
por: Liu, Chengli, et al.
Publicado: (2023)

Cerebral Hemodynamic Changes After Revascularization in Patients With Hemorrhagic Moyamoya Disease
por: Kang, Kaijiang, et al.
Publicado: (2020)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells
por: Guo, Zhentao, et al.
Publicado: (2014)

Hypoglycemia After Gastric Bypass Successfully Treated With Calcium Channel Blockers: Two Case Reports
por: Ames, Angharad, et al.
Publicado: (2019)

Pleiotropic Effects of Calcium Channel Blockers
por: Preston Mason, R.
Publicado: (2012)

Calcium channel blockers and Alzheimer's disease★
por: Tan, Yi, et al.
Publicado: (2012)

Discovery and Development of Calcium Channel Blockers
por: Godfraind, Théophile
Publicado: (2017)

Clinical response to calcium channel blockers in a hemodynamically unstable patient with reactive idiopathic pulmonary arterial hypertension
por: Kopec, Grzegorz, et al.
Publicado: (2017)

A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention
por: Wang, Ji-Guang
Publicado: (2009)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Angiographic Characteristics of Cerebral Perfusion and Hemodynamics of the Bridging Artery After Surgical Treatment of Unilateral Moyamoya Disease
por: Zhang, Kun, et al.
Publicado: (2022)

Effects of calcium channel blockers on potassium homeostasis.
por: Freed, M. I., et al.
Publicado: (1991)

Treatment of calcium channel blocker overdose with levosimendan
por: Sencan, A, et al.
Publicado: (2011)

Neuroprotective effects of blockers for T-type calcium channels
por: Wildburger, Norelle C, et al.
Publicado: (2009)

Calcium channel blocker overdose: Experience with amlodipine
por: Ghosh, Supradip, et al.
Publicado: (2008)

The role of calcium channel blockers in wound healing
por: Mojiri-Forushani, Hoda
Publicado: (2018)

Calcium Channel Blocker-induced Gingival Overgrowth
por: Matsuura, Hiroki, et al.
Publicado: (2018)

Repurposing calcium channel blockers as antiviral drugs
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2020)

Are calcium channel blockers related to lung cancer?
por: Rattanathanoo, Ratchanon, et al.
Publicado: (2023)

Diindolylmethane Derivatives: New Selective Blockers for T-Type Calcium Channels
por: Wang, Dan, et al.
Publicado: (2022)

Effects of Calcium Ion, Calpains, and Calcium Channel Blockers on Retinitis Pigmentosa
por: Nakazawa, Mitsuru
Publicado: (2011)

Progress on Complications of Direct Bypass for Moyamoya Disease
por: Yu, Jinlu, et al.
Publicado: (2016)

Calcium channel blockers reduce the antiplatelet effect of clopidogrel
por: Siller-Matula, Jolanta M, et al.
Publicado: (2008)

Prognostic factors of acute calcium-channel blocker poisonings
por: Karyo, S, et al.
Publicado: (2008)

Bio-Inspired Voltage-Dependent Calcium Channel Blockers
por: Yang, Tingting, et al.
Publicado: (2013)

Calcium channel blocker in patients with chronic kidney disease
por: Ohno, Shoko, et al.
Publicado: (2021)

Herbicidal properties of antihypertensive drugs: calcium channel blockers
por: Abdullah, Hannan Safiyyah Tan Sian Hui, et al.
Publicado: (2021)

Calcium Channel Blocker Toxicity: A Practical Approach
por: Alshaya, Omar A, et al.
Publicado: (2022)

Overcoming Confounding to Characterize the Effects of Calcium Channel Blockers
por: Rajagopal, Sudarshan, et al.
Publicado: (2023)

Calcium channel blockers and beta-blockers could increased mortality of patients with COVID-19
por: Esteban-Lucia, L, et al.
Publicado: (2021)

Beta-Blocker and Calcium Channel Blocker Toxicity With BRASH Syndrome: A Case Report
por: Martinez, Adolfo, et al.
Publicado: (2023)

A comment on “Contralateral cerebral hemodynamic changes after unilateral direct revascularization in patients with moyamoya disease”
por: Esposito, Giuseppe, et al.
Publicado: (2011)

Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome
por: Kang, Kaijiang, et al.
Publicado: (2017)

Angiographic Outcomes of Direct and Combined Bypass Surgery in Moyamoya Disease
por: Ge, Peicong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0sag4315ok9vn4sdpo67krj508